Close Menu

Chris van Ingen, Ulf Jonsson

Premium
Chris van Ingen, president of Agilent’s Bio-Analytical Measurement business, will retire on Oct. 31, the last day of the company’s fiscal year, Agilent announced last month. Van Ingen, 61, has been at Agilent and Hewlett Packard, which Agilent was originally part of, for 30 years. He joined HP in 1977 as a sales engineer in the Netherlands and was appointed to his current position in May 2001. No replacement has been named.
 

 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The UK has given emergency authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine, the Associated Press reports.

A US advisory committee says healthcare workers and nursing home residents should be prioritized to receive a SARS-CoV-2 vaccine, according to the Financial Times.

The Wall Street Journal reports North Korean hackers have targeted half a dozen companies developing SARS-CoV-2 vaccines.

In Cell this week: long-term SARS-CoV-2 shedding, examination of the effects of a coronavirus spike protein mutation, and more.